Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Related Articles by Review for PubMed (Select 15934915)

1.

Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition.

Harwood HJ Jr.

Expert Opin Ther Targets. 2005 Apr;9(2):267-81. Review.

PMID:
15934915
2.

Acetyl-CoA carboxylase inhibition for the treatment of metabolic syndrome.

Harwood HJ Jr.

Curr Opin Investig Drugs. 2004 Mar;5(3):283-9. Review.

PMID:
15083594
3.

Inhibitors of mammalian acetyl-CoA carboxylase.

Corbett JW, Harwood JH Jr.

Recent Pat Cardiovasc Drug Discov. 2007 Nov;2(3):162-80. Review.

PMID:
18221116
4.

Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.

Schreurs M, Kuipers F, van der Leij FR.

Obes Rev. 2010 May;11(5):380-8. doi: 10.1111/j.1467-789X.2009.00642.x. Epub 2009 Aug 20. Review.

PMID:
19694967
5.

Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Kusunoki J, Kanatani A, Moller DE.

Endocrine. 2006 Feb;29(1):91-100. Review.

PMID:
16622296
6.

Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008.

Corbett JW.

Expert Opin Ther Pat. 2009 Jul;19(7):943-56. doi: 10.1517/13543770902862180. Review.

PMID:
19552511
7.

Acetyl-CoA carboxylase-a as a novel target for cancer therapy.

Wang C, Rajput S, Watabe K, Liao DF, Cao D.

Front Biosci (Schol Ed). 2010 Jan 1;2:515-26. Review.

PMID:
20036965
8.

Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.

Folmes CD, Lopaschuk GD.

Cardiovasc Res. 2007 Jan 15;73(2):278-87. Epub 2006 Oct 20. Review.

9.

Structure, function and selective inhibition of bacterial acetyl-coa carboxylase.

Polyak SW, Abell AD, Wilce MC, Zhang L, Booker GW.

Appl Microbiol Biotechnol. 2012 Feb;93(3):983-92. doi: 10.1007/s00253-011-3796-z. Epub 2011 Dec 20. Review.

PMID:
22183085
10.

Targeting acetyl-CoA carboxylases: small molecular inhibitors and their therapeutic potential.

Luo DX, Tong DJ, Rajput S, Wang C, Liao DF, Cao D, Maser E.

Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):168-84. Review.

PMID:
22339356
11.
12.

11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.

Schnackenberg CG.

Curr Opin Investig Drugs. 2008 Mar;9(3):295-300. Review.

PMID:
18311666
13.

Fatty acid metabolism: target for metabolic syndrome.

Wakil SJ, Abu-Elheiga LA.

J Lipid Res. 2009 Apr;50 Suppl:S138-43. doi: 10.1194/jlr.R800079-JLR200. Epub 2008 Dec 1. Review.

15.
16.

Structure and regulation of acetyl-CoA carboxylase genes of metazoa.

Barber MC, Price NT, Travers MT.

Biochim Biophys Acta. 2005 Mar 21;1733(1):1-28. Epub 2005 Jan 22. Review.

PMID:
15749055
17.

[Metabolic syndrome. Part III: its prevention and therapeutic management].

Pacholczyk M, Ferenc T, Kowalski J.

Postepy Hig Med Dosw (Online). 2008 Oct 16;62:559-70. Review. Polish.

18.

Regulation of acetyl-CoA carboxylase.

Brownsey RW, Boone AN, Elliott JE, Kulpa JE, Lee WM.

Biochem Soc Trans. 2006 Apr;34(Pt 2):223-7. Review.

PMID:
16545081
19.

Treatment of hypertension in metabolic syndrome: implications of recent clinical trials.

Makaryus AN, Akhrass P, McFarlane SI.

Curr Diab Rep. 2009 Jun;9(3):229-37. Review.

PMID:
19490825
20.

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.

PMID:
18669160
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk